Drive payer submission readiness for Phase 2 and 3 product

The collaboration is centered on standardization and the promotion of safety data sharing when it comes to ground handling.

Rob Sobie outlines the importance of supply chain transparency for the benefit of patients.

The 13,400 square-foot Belgium site will expand the company’s branded standardized bioprocessing, cryopreservation, and distribution solution for the cell therapy market, with a focus on leukapheresis starting materials.

Steve Silvestro explains the value of artificial intelligence in launch plans, benefits to integrating DTC and HCP marketing strategies, and more.

The conference returns to Lyon, France and promises a timely and relevant agenda that attendees will resonate with.

JAMA study indicates Canada may have a more resilient drug supply chain or different thresholds for reporting and responding to issues compared with the United States.